Drug Induced Retinopathy - Pharma

Relevant Publications

Enhanced Ocular Delivery of Beva via Ultra-Small Polymeric Micelles for Noninvasive Anti-VEGF Therapy.

Issue Release: 2024

Solar retinopathy related to antidepressant use in a patient with major depressive disorder: a case report.

Issue Release: 2024

ROS-Responsive Nanoparticles with Antioxidative Effect for the treatment of Diabetic Retinopathy.

Issue Release: 2024

Review of lipocalin-2-mediated effects in diabetic retinopathy.

Issue Release: 2024

Role of MST2/YAP1 signaling pathway in retinal cells apoptosis and diabetic retinopathy.

Issue Release: 2024

Ocular pharmacological and biochemical profiles of 6-thioguanine: a drug repurposing study.

Issue Release: 2024

Cellular Modeling of CLN6 with IPSC-derived Neurons and Glia.

Issue Release: 2024

Human umbilical cord mesenchymal stem cells derived-exosomes on VEGF-A in hypoxic-induced mice retinal astrocytes and mice model of retinopathy of prematurity.

Issue Release: 2024

Effect of madecassic acid on retinal oxidative stress, inflammation and Growth Factors in streptozotocin-induced diabetic rats.

Issue Release: 2024

Effects of mesenchymal stromal cells and human recombinant Nerve Growth Factor delivered by bioengineered human corneal lenticule on an innovative model of diabetic retinopathy.

Issue Release: 2024

Effect of Danggui Buxue decoction on hypoxia-induced injury of retinal Müller cells .

Issue Release: 2024

The Anti-Diabetic Drug Metformin Suppresses Pathological Retinal Angiogenesis via Blocking the mTORC1 Signaling Pathway in Mice (Metformin Suppresses Pathological Angiogenesis).

Issue Release: 2024

Study on the correlation between iris blood flow, iris thickness and pupil diameter in the resting state and after pharmacological mydriasis in patients with diabetes mellitus.

Issue Release: 2024

A promising case of preclinical-clinical translation: β-adrenoceptor blockade from the oxygen-induced retinopathy model to retinopathy of prematurity.

Issue Release: 2024

A Nanogel Formulation of Anti-VEGF Peptide for Ocular Neovascularization Treatment.

Issue Release: 2024

Prospects and limitations of cumate-inducible lentivirus as a tool for investigating VEGF-A-mediated pathology in diabetic retinopathy.

Issue Release: 2024

Aldose reductase with quinolone antibiotics interaction: In vitro and in silico approach of its relationship with diabetic complications.

Issue Release: 2024

Molecular mechanisms of Buqing granule for the treatment of diabetic retinopathy: Network pharmacology analysis and experimental validation.

Issue Release: 2024

PREVALENCE OF DIDANOSINE-RELATED RETINAL TOXICITY AT AN URBAN ACADEMIC CENTER AS DIAGNOSED WITH ULTRA-WIDEFIELD IMAGING.

Issue Release: 2024

Targeting ferroptosis: a novel therapeutic strategy for the treatment of retinal diseases.

Issue Release: 2024

How Are Participants Protected?

How Does Cellular Stress Impact Drug Development?

What are the Regulatory Requirements for Generic Drugs?

What Role Do Pharmacists Play in Patient Education?

Why is Generic Competition Important?

What are Contract Research Organizations (CROs)?

What is Medication Management?

How Can Pharma Companies Improve Patient Education?

Why is Transitional Care Important in Pharma?

What is Transitional Care?

Partnered Content Networks

Relevant Topics